Jignesh Dalal
Pediatric Hematology-Oncology · Kansas City, MONPI 1518909191
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Novartis at 59.0% of the total. Reporting peaked in 2021 at $1,812 and has fallen 86.3% since, to $248 in 2025.
Across 68 payments — averaging $61.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Adaptive Biotechnologies Corporation$552
- Amgen$169
- Takeda Pharmaceuticals U.S.A., Inc.$161
- Bayer$122
- Sanofi$114
- plus $599 from 13 others
Across 28 payments — averaging $6487.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$162K
- Mallinckrodt Enterprises LLC$16K
- Amgen$3K
- Adaptive Biotechnologies Corporation$900
What the payments were for
- Consulting fees$1,12527%
- Travel & lodging$1,33632%
- Food & beverage$1,72341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $2,467 |
| Adaptive Biotechnologies Corporation | 2 | $552 |
| Amgen | 5 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $161 |
| Bayer | 5 | $122 |
| Sanofi | 5 | $114 |
| Syndax Pharmaceuticals, Inc. | 1 | $96 |
| CSL Behring | 5 | $86 |
| AstraZeneca | 5 | $82 |
| Novo Nordisk | 4 | $67 |
| Merck | 3 | $58 |
| Jazz Pharmaceuticals Inc. | 3 | $58 |
| Shire North American Group Inc | 2 | $31 |
| Chiesi USA, Inc. | 2 | $30 |
| Genentech USA, Inc. | 1 | $24 |
| Acrotech Biopharma Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $16 |
| Global Blood Therapeutics, Inc. | 1 | $14 |
| Grifols USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,184 in reported general payments places this provider in the 75th percentile of 78 pediatric hematology-oncology providers in Missouri.
See all pediatric hematology-oncology providers in Missouri →
Other pediatric hematology-oncology in Kansas City
- Michael SilveyKansas City$124K
- Lauren AmosKansas City$109K
- Ibrahim AhmedKansas City$79K
- Erin GuestKansas City$21K
- Shannon CarpenterKansas City$19K
- Gerald WoodsKansas City$11K
- Brian WicklundKansas City$9K
- Keith AugustKansas City$7K
- Terrie FlattKansas City$5K
- Sara McElroyKansas City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.